Variant report
Variant | esv1850880 |
---|---|
Chromosome Location | chr5:7917101-7923683 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:23)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:23 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BHLHE40 | chr5:7918663-7918695 | GM12878 | blood: | n/a | n/a |
2 | CEBPB | chr5:7917466-7917815 | HepG2 | liver: | n/a | chr5:7917640-7917651 |
3 | CEBPB | chr5:7917463-7917820 | IMR90 | lung: | n/a | chr5:7917640-7917651 |
4 | CEBPB | chr5:7917491-7917819 | K562 | blood: | n/a | chr5:7917640-7917651 |
5 | CEBPB | chr5:7917518-7917789 | A549 | lung: | n/a | chr5:7917640-7917651 |
6 | CEBPB | chr5:7917486-7917794 | Hela-S3 | cervix: | n/a | chr5:7917640-7917651 |
7 | EP300 | chr5:7918006-7918047 | K562 | blood: | n/a | n/a |
8 | FOXA2 | chr5:7920040-7920268 | A549 | lung: | n/a | n/a |
9 | IRF1 | chr5:7920575-7920740 | K562 | blood: | n/a | n/a |
10 | IRF1 | chr5:7918658-7918797 | K562 | blood: | n/a | n/a |
11 | MAFF | chr5:7917890-7918184 | K562 | blood: | n/a | chr5:7917995-7918013 chr5:7918033-7918051 |
12 | MAFF | chr5:7917902-7918187 | HepG2 | liver: | n/a | chr5:7917995-7918013 chr5:7918033-7918051 |
13 | MAFK | chr5:7917984-7918089 | K562 | blood: | n/a | chr5:7918035-7918050 |
14 | MAFK | chr5:7917898-7918155 | HepG2 | liver: | n/a | chr5:7918035-7918050 |
15 | MAFK | chr5:7917905-7918186 | HepG2 | liver: | n/a | chr5:7918035-7918050 |
16 | MAFK | chr5:7917863-7918214 | IMR90 | lung: | n/a | chr5:7918035-7918050 |
17 | POLR2A | chr5:7922217-7922347 | K562 | blood: | n/a | n/a |
18 | POLR2A | chr5:7921838-7922007 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | POLR2A | chr5:7917267-7917631 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | RAD21 | chr5:7917670-7917673 | HepG2 | liver: | n/a | n/a |
21 | RCOR1 | chr5:7917834-7917961 | K562 | blood: | n/a | n/a |
22 | RFX5 | chr5:7921468-7921605 | K562 | blood: | n/a | n/a |
23 | WRNIP1 | chr5:7919207-7919210 | GM12878 | blood: | n/a | n/a |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000251168 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs142434421 | chr5:7917132-7917133 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs116357701 | chr5:7917133-7917134 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs2388771 | chr5:7917137-7917138 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs575498736 | chr5:7917149-7917150 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs540079828 | chr5:7917173-7917174 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs553686891 | chr5:7917203-7917204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs183194807 | chr5:7917204-7917205 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs370169757 | chr5:7917214-7917215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs555303775 | chr5:7917251-7917252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs187490917 | chr5:7917309-7917310 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs575135950 | chr5:7917350-7917351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs12186809 | chr5:7917360-7917361 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
13 | rs150901748 | chr5:7917361-7917362 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs577755489 | chr5:7917400-7917401 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs191988608 | chr5:7917436-7917437 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs559939525 | chr5:7917516-7917517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs574793447 | chr5:7917534-7917535 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs529119922 | chr5:7917571-7917572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs12189183 | chr5:7917580-7917581 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
20 | rs183378006 | chr5:7917601-7917602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs530854375 | chr5:7917737-7917738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs76231165 | chr5:7917739-7917740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs145532675 | chr5:7917741-7917742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs147807567 | chr5:7917767-7917768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs141197386 | chr5:7917781-7917782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs567081157 | chr5:7917813-7917814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs187759577 | chr5:7917836-7917837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs192463357 | chr5:7917839-7917840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs540424280 | chr5:7917882-7917883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs162273 | chr5:7917934-7917935 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
31 | rs28829123 | chr5:7917953-7917954 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs148099112 | chr5:7917989-7917990 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs374983505 | chr5:7920044-7920045 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs557748709 | chr5:7920077-7920078 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs562895254 | chr5:7920214-7920215 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs186061911 | chr5:7920247-7920248 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs545366538 | chr5:7920248-7920249 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs191344144 | chr5:7920255-7920256 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs573984136 | chr5:7920587-7920588 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs369511260 | chr5:7920651-7920652 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs70940767 | chr5:7920682-7920683 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs398108567 | chr5:7920691-7920692 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs80145706 | chr5:7920692-7920693 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs190700940 | chr5:7920700-7920701 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs182983424 | chr5:7920716-7920717 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs77056991 | chr5:7921478-7921479 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs188403610 | chr5:7921553-7921554 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs543378117 | chr5:7921596-7921597 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs558671768 | chr5:7921842-7921843 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs572290456 | chr5:7921849-7921850 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Lung cancer | 21911935 | CNVD |
Cri-du chat syndrome | 21549014 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
renal disease | 17924346 | CNVD |
abnormal development | 18461090 | CNVD |
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Developmental delay | 21147756 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Melanoma | 22183965 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Autism | 22495311 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Cancer | 22183965 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Intellectual disability | 22102821 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Ependymoma | 20639864 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:7909800-7917600 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
2 | chr5:7915400-7917200 | Enhancers | Osteobl | bone |
3 | chr5:7917600-7918000 | Enhancers | Rectal Mucosa Donor 31 | rectum |